Thulio Lemos

Background

About Thulio Lemos

I am a Pharmacist graduated from the Federal University of Alfenas (MG-Brazil). I am a researcher in the development of new drugs and medications. I hold a Master's degree from the Federal University of Alfenas, with a focus on the development of analytical methods for drug quantification by HPLC and the study of polymorphism. Currently, I am a Ph.D. student in Pharmaceutical Sciences at São Paulo State University (UNESP-Araraquara) with an emphasis on materials science applied to pharmacy, particularly quantum dots and contrast agents for magnetic resonance imaging and fluorescence. I am seeking employment and posdoc position in the field of Research and Development of pharmaceuticals, quality control of pharmaceuticals, or analytical development and stability. To access my publications, please visit the Google Scholar link: & hl=pt-BR. Ph.D.(UNESP-Pharmacy):"Development of Bimodal Agents based on Fe and Zn." I have acquired expertise in techniques such as Fluorescence Spectroscopy (emission and absorption) and Magnetic Resonance Imaging (MRI). During my one-year tenure at the MINT laboratory (University of Angers), I focused on formulating polymeric nanoparticles for biological applications. My skills include Dynamic Light Scattering (Size and Zeta potential), ICP, MRI, as well as cytotoxicity and uptake analyses. Scholarship Professor (Pharmacy-UNESP) in 2022: Quality control of pharmaceuticals and medications. Master's degree (Unifal-Pharmacy):"Chemical-pharmaceutical studies of solid forms of allopurinol." I developed expertise in characterization studies using FTIR, DSC, TG, and X-ray diffraction, analytical method validation (according to RDC166/2017), solubility (technical note 003/2013), accelerated stability testing (following RDC 319/2019), and intrinsic dissolution (USP, 2017). HPLC Course at Farmalfenas Jr. in 2018 and 2019. I conducted courses on chromatographic techniques with practical applications, totaling 80 hours of instruction. Internship in Analytical Development (UNIFAL-MG) 2017:"CNPq/ANVISA Call No. 12/2015." Conducted studies for the development of standardized formulations of capsules for magistral use and the respective methods of obtaining them (line 3).